Global Mitral Regurgitation Market Growth (Status and Outlook) 2023-2029

January 2023 | 121 pages | ID: GC8818C22F0AEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Mitral regurgitation (MR) is the backflow of blood from the left ventricle into the left atrium during left ventricular systole. The mitral valve is located in the opening between the left atrium and the left ventricle. It opens to allow blood from the left atrium to fill the left ventricle. When the left ventricle contracts, the mitral valve closes so that pumped blood can only flow into the aorta. When the mitral valve is not fully closed, some blood can leak back into the left atrium. Mitral regurgitation can be divided into primary and secondary MR according to the pathogenesis. Primary mitral regurgitation is due to the pathological changes of one or more of the mitral valve leaflets, valve annulus, chordae tendineae and papillary muscles, such as degenerative disease or rheumatic disease, which cause the mitral valve to fail to close normally. Secondary mitral valve regurgitation is functional mitral valve regurgitation, which is caused by the disease of the heart itself or the valve supporting structure, such as pathological changes of the myocardium leading to pathological dilatation of the left ventricle and mitral valve annulus or Mitral regurgitation due to localized displacement of the left ventricle and subvalvular device. The current quantitative assessment of mitral valve regurgitation, the current standards of various guidelines and documents are not completely consistent, generally divided into mild, moderate and severe, this classification is relatively broad, can not well reflect the changes and manifestations before and after surgery effect of surgery. In the MitraClip system clinical trial, mitral regurgitation was divided into no (0+), mild (1+), moderate (2+), moderate to severe (3+), severe (4+), and then more This classification method is used in several clinical studies of mitral valve regurgitation interventional therapy.

LPI (LP Information)' newest research report, the “Mitral Regurgitation Industry Forecast” looks at past sales and reviews total world Mitral Regurgitation sales in 2022, providing a comprehensive analysis by region and market sector of projected Mitral Regurgitation sales for 2023 through 2029. With Mitral Regurgitation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mitral Regurgitation industry.

This Insight Report provides a comprehensive analysis of the global Mitral Regurgitation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mitral Regurgitation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mitral Regurgitation market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mitral Regurgitation and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mitral Regurgitation.

The global Mitral Regurgitation market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Mitral Regurgitation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Mitral Regurgitation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Mitral Regurgitation is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Mitral Regurgitation players cover Edwards Lifesciences, Abbott, CardioSolution, NeoChord, Mitralign, Medtronic, Boston Scientific, Mitralix and Shanghai Hanyu Medical Technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Mitral Regurgitation market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Primary Mitral Regurgitation
  • Secondary Mitral Regurgitation
Segmentation by application
  • Transapical
  • Via Stock and Via Interstitial
  • Right Internal Jugular Vein
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Edwards Lifesciences
  • Abbott
  • CardioSolution
  • NeoChord
  • Mitralign
  • Medtronic
  • Boston Scientific
  • Mitralix
  • Shanghai Hanyu Medical Technology
  • Valgen Holding Corporation
  • NeoChord
  • CoreMedic
  • Babic Chord
  • Gore Medical
  • Valtech Cardio
  • Transcardiac
  • ChoRe
  • AVVIE
  • Cardiovalve
  • HighLife SAS
  • Neovasc
  • MitrAssist Lifesciences
  • Shanghai NewMed Medical
  • Peijia Medical
  • MicroPort CardioFlow Medtech
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Mitral Regurgitation Market Size 2018-2029
  2.1.2 Mitral Regurgitation Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Mitral Regurgitation Segment by Type
  2.2.1 Primary Mitral Regurgitation
  2.2.2 Secondary Mitral Regurgitation
2.3 Mitral Regurgitation Market Size by Type
  2.3.1 Mitral Regurgitation Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Mitral Regurgitation Market Size Market Share by Type (2018-2023)
2.4 Mitral Regurgitation Segment by Application
  2.4.1 Transapical
  2.4.2 Via Stock and Via Interstitial
  2.4.3 Right Internal Jugular Vein
2.5 Mitral Regurgitation Market Size by Application
  2.5.1 Mitral Regurgitation Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Mitral Regurgitation Market Size Market Share by Application (2018-2023)

3 MITRAL REGURGITATION MARKET SIZE BY PLAYER

3.1 Mitral Regurgitation Market Size Market Share by Players
  3.1.1 Global Mitral Regurgitation Revenue by Players (2018-2023)
  3.1.2 Global Mitral Regurgitation Revenue Market Share by Players (2018-2023)
3.2 Global Mitral Regurgitation Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MITRAL REGURGITATION BY REGIONS

4.1 Mitral Regurgitation Market Size by Regions (2018-2023)
4.2 Americas Mitral Regurgitation Market Size Growth (2018-2023)
4.3 APAC Mitral Regurgitation Market Size Growth (2018-2023)
4.4 Europe Mitral Regurgitation Market Size Growth (2018-2023)
4.5 Middle East & Africa Mitral Regurgitation Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Mitral Regurgitation Market Size by Country (2018-2023)
5.2 Americas Mitral Regurgitation Market Size by Type (2018-2023)
5.3 Americas Mitral Regurgitation Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Mitral Regurgitation Market Size by Region (2018-2023)
6.2 APAC Mitral Regurgitation Market Size by Type (2018-2023)
6.3 APAC Mitral Regurgitation Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Mitral Regurgitation by Country (2018-2023)
7.2 Europe Mitral Regurgitation Market Size by Type (2018-2023)
7.3 Europe Mitral Regurgitation Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Mitral Regurgitation by Region (2018-2023)
8.2 Middle East & Africa Mitral Regurgitation Market Size by Type (2018-2023)
8.3 Middle East & Africa Mitral Regurgitation Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MITRAL REGURGITATION MARKET FORECAST

10.1 Global Mitral Regurgitation Forecast by Regions (2024-2029)
  10.1.1 Global Mitral Regurgitation Forecast by Regions (2024-2029)
  10.1.2 Americas Mitral Regurgitation Forecast
  10.1.3 APAC Mitral Regurgitation Forecast
  10.1.4 Europe Mitral Regurgitation Forecast
  10.1.5 Middle East & Africa Mitral Regurgitation Forecast
10.2 Americas Mitral Regurgitation Forecast by Country (2024-2029)
  10.2.1 United States Mitral Regurgitation Market Forecast
  10.2.2 Canada Mitral Regurgitation Market Forecast
  10.2.3 Mexico Mitral Regurgitation Market Forecast
  10.2.4 Brazil Mitral Regurgitation Market Forecast
10.3 APAC Mitral Regurgitation Forecast by Region (2024-2029)
  10.3.1 China Mitral Regurgitation Market Forecast
  10.3.2 Japan Mitral Regurgitation Market Forecast
  10.3.3 Korea Mitral Regurgitation Market Forecast
  10.3.4 Southeast Asia Mitral Regurgitation Market Forecast
  10.3.5 India Mitral Regurgitation Market Forecast
  10.3.6 Australia Mitral Regurgitation Market Forecast
10.4 Europe Mitral Regurgitation Forecast by Country (2024-2029)
  10.4.1 Germany Mitral Regurgitation Market Forecast
  10.4.2 France Mitral Regurgitation Market Forecast
  10.4.3 UK Mitral Regurgitation Market Forecast
  10.4.4 Italy Mitral Regurgitation Market Forecast
  10.4.5 Russia Mitral Regurgitation Market Forecast
10.5 Middle East & Africa Mitral Regurgitation Forecast by Region (2024-2029)
  10.5.1 Egypt Mitral Regurgitation Market Forecast
  10.5.2 South Africa Mitral Regurgitation Market Forecast
  10.5.3 Israel Mitral Regurgitation Market Forecast
  10.5.4 Turkey Mitral Regurgitation Market Forecast
  10.5.5 GCC Countries Mitral Regurgitation Market Forecast
10.6 Global Mitral Regurgitation Forecast by Type (2024-2029)
10.7 Global Mitral Regurgitation Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Edwards Lifesciences
  11.1.1 Edwards Lifesciences Company Information
  11.1.2 Edwards Lifesciences Mitral Regurgitation Product Offered
  11.1.3 Edwards Lifesciences Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Edwards Lifesciences Main Business Overview
  11.1.5 Edwards Lifesciences Latest Developments
11.2 Abbott
  11.2.1 Abbott Company Information
  11.2.2 Abbott Mitral Regurgitation Product Offered
  11.2.3 Abbott Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Abbott Main Business Overview
  11.2.5 Abbott Latest Developments
11.3 CardioSolution
  11.3.1 CardioSolution Company Information
  11.3.2 CardioSolution Mitral Regurgitation Product Offered
  11.3.3 CardioSolution Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 CardioSolution Main Business Overview
  11.3.5 CardioSolution Latest Developments
11.4 NeoChord
  11.4.1 NeoChord Company Information
  11.4.2 NeoChord Mitral Regurgitation Product Offered
  11.4.3 NeoChord Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 NeoChord Main Business Overview
  11.4.5 NeoChord Latest Developments
11.5 Mitralign
  11.5.1 Mitralign Company Information
  11.5.2 Mitralign Mitral Regurgitation Product Offered
  11.5.3 Mitralign Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Mitralign Main Business Overview
  11.5.5 Mitralign Latest Developments
11.6 Medtronic
  11.6.1 Medtronic Company Information
  11.6.2 Medtronic Mitral Regurgitation Product Offered
  11.6.3 Medtronic Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Medtronic Main Business Overview
  11.6.5 Medtronic Latest Developments
11.7 Boston Scientific
  11.7.1 Boston Scientific Company Information
  11.7.2 Boston Scientific Mitral Regurgitation Product Offered
  11.7.3 Boston Scientific Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Boston Scientific Main Business Overview
  11.7.5 Boston Scientific Latest Developments
11.8 Mitralix
  11.8.1 Mitralix Company Information
  11.8.2 Mitralix Mitral Regurgitation Product Offered
  11.8.3 Mitralix Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Mitralix Main Business Overview
  11.8.5 Mitralix Latest Developments
11.9 Shanghai Hanyu Medical Technology
  11.9.1 Shanghai Hanyu Medical Technology Company Information
  11.9.2 Shanghai Hanyu Medical Technology Mitral Regurgitation Product Offered
  11.9.3 Shanghai Hanyu Medical Technology Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Shanghai Hanyu Medical Technology Main Business Overview
  11.9.5 Shanghai Hanyu Medical Technology Latest Developments
11.10 Valgen Holding Corporation
  11.10.1 Valgen Holding Corporation Company Information
  11.10.2 Valgen Holding Corporation Mitral Regurgitation Product Offered
  11.10.3 Valgen Holding Corporation Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Valgen Holding Corporation Main Business Overview
  11.10.5 Valgen Holding Corporation Latest Developments
11.11 NeoChord
  11.11.1 NeoChord Company Information
  11.11.2 NeoChord Mitral Regurgitation Product Offered
  11.11.3 NeoChord Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 NeoChord Main Business Overview
  11.11.5 NeoChord Latest Developments
11.12 CoreMedic
  11.12.1 CoreMedic Company Information
  11.12.2 CoreMedic Mitral Regurgitation Product Offered
  11.12.3 CoreMedic Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 CoreMedic Main Business Overview
  11.12.5 CoreMedic Latest Developments
11.13 Babic Chord
  11.13.1 Babic Chord Company Information
  11.13.2 Babic Chord Mitral Regurgitation Product Offered
  11.13.3 Babic Chord Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.13.4 Babic Chord Main Business Overview
  11.13.5 Babic Chord Latest Developments
11.14 Gore Medical
  11.14.1 Gore Medical Company Information
  11.14.2 Gore Medical Mitral Regurgitation Product Offered
  11.14.3 Gore Medical Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.14.4 Gore Medical Main Business Overview
  11.14.5 Gore Medical Latest Developments
11.15 Valtech Cardio
  11.15.1 Valtech Cardio Company Information
  11.15.2 Valtech Cardio Mitral Regurgitation Product Offered
  11.15.3 Valtech Cardio Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.15.4 Valtech Cardio Main Business Overview
  11.15.5 Valtech Cardio Latest Developments
11.16 Transcardiac
  11.16.1 Transcardiac Company Information
  11.16.2 Transcardiac Mitral Regurgitation Product Offered
  11.16.3 Transcardiac Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.16.4 Transcardiac Main Business Overview
  11.16.5 Transcardiac Latest Developments
11.17 ChoRe
  11.17.1 ChoRe Company Information
  11.17.2 ChoRe Mitral Regurgitation Product Offered
  11.17.3 ChoRe Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.17.4 ChoRe Main Business Overview
  11.17.5 ChoRe Latest Developments
11.18 AVVIE
  11.18.1 AVVIE Company Information
  11.18.2 AVVIE Mitral Regurgitation Product Offered
  11.18.3 AVVIE Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.18.4 AVVIE Main Business Overview
  11.18.5 AVVIE Latest Developments
11.19 Cardiovalve
  11.19.1 Cardiovalve Company Information
  11.19.2 Cardiovalve Mitral Regurgitation Product Offered
  11.19.3 Cardiovalve Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.19.4 Cardiovalve Main Business Overview
  11.19.5 Cardiovalve Latest Developments
11.20 HighLife SAS
  11.20.1 HighLife SAS Company Information
  11.20.2 HighLife SAS Mitral Regurgitation Product Offered
  11.20.3 HighLife SAS Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.20.4 HighLife SAS Main Business Overview
  11.20.5 HighLife SAS Latest Developments
11.21 Neovasc
  11.21.1 Neovasc Company Information
  11.21.2 Neovasc Mitral Regurgitation Product Offered
  11.21.3 Neovasc Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.21.4 Neovasc Main Business Overview
  11.21.5 Neovasc Latest Developments
11.22 MitrAssist Lifesciences
  11.22.1 MitrAssist Lifesciences Company Information
  11.22.2 MitrAssist Lifesciences Mitral Regurgitation Product Offered
  11.22.3 MitrAssist Lifesciences Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.22.4 MitrAssist Lifesciences Main Business Overview
  11.22.5 MitrAssist Lifesciences Latest Developments
11.23 Shanghai NewMed Medical
  11.23.1 Shanghai NewMed Medical Company Information
  11.23.2 Shanghai NewMed Medical Mitral Regurgitation Product Offered
  11.23.3 Shanghai NewMed Medical Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.23.4 Shanghai NewMed Medical Main Business Overview
  11.23.5 Shanghai NewMed Medical Latest Developments
11.24 Peijia Medical
  11.24.1 Peijia Medical Company Information
  11.24.2 Peijia Medical Mitral Regurgitation Product Offered
  11.24.3 Peijia Medical Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.24.4 Peijia Medical Main Business Overview
  11.24.5 Peijia Medical Latest Developments
11.25 MicroPort CardioFlow Medtech
  11.25.1 MicroPort CardioFlow Medtech Company Information
  11.25.2 MicroPort CardioFlow Medtech Mitral Regurgitation Product Offered
  11.25.3 MicroPort CardioFlow Medtech Mitral Regurgitation Revenue, Gross Margin and Market Share (2018-2023)
  11.25.4 MicroPort CardioFlow Medtech Main Business Overview
  11.25.5 MicroPort CardioFlow Medtech Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Mitral Regurgitation Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Primary Mitral Regurgitation
Table 3. Major Players of Secondary Mitral Regurgitation
Table 4. Mitral Regurgitation Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Mitral Regurgitation Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Mitral Regurgitation Market Size Market Share by Type (2018-2023)
Table 7. Mitral Regurgitation Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Mitral Regurgitation Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Mitral Regurgitation Market Size Market Share by Application (2018-2023)
Table 10. Global Mitral Regurgitation Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Mitral Regurgitation Revenue Market Share by Player (2018-2023)
Table 12. Mitral Regurgitation Key Players Head office and Products Offered
Table 13. Mitral Regurgitation Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Mitral Regurgitation Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Mitral Regurgitation Market Size Market Share by Regions (2018-2023)
Table 18. Global Mitral Regurgitation Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Mitral Regurgitation Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Mitral Regurgitation Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Mitral Regurgitation Market Size Market Share by Country (2018-2023)
Table 22. Americas Mitral Regurgitation Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Mitral Regurgitation Market Size Market Share by Type (2018-2023)
Table 24. Americas Mitral Regurgitation Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Mitral Regurgitation Market Size Market Share by Application (2018-2023)
Table 26. APAC Mitral Regurgitation Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Mitral Regurgitation Market Size Market Share by Region (2018-2023)
Table 28. APAC Mitral Regurgitation Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Mitral Regurgitation Market Size Market Share by Type (2018-2023)
Table 30. APAC Mitral Regurgitation Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Mitral Regurgitation Market Size Market Share by Application (2018-2023)
Table 32. Europe Mitral Regurgitation Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Mitral Regurgitation Market Size Market Share by Country (2018-2023)
Table 34. Europe Mitral Regurgitation Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Mitral Regurgitation Market Size Market Share by Type (2018-2023)
Table 36. Europe Mitral Regurgitation Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Mitral Regurgitation Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Mitral Regurgitation Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Mitral Regurgitation Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Mitral Regurgitation Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Mitral Regurgitation Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Mitral Regurgitation Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Mitral Regurgitation Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Mitral Regurgitation
Table 45. Key Market Challenges & Risks of Mitral Regurgitation
Table 46. Key Industry Trends of Mitral Regurgitation
Table 47. Global Mitral Regurgitation Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Mitral Regurgitation Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Mitral Regurgitation Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Mitral Regurgitation Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Edwards Lifesciences Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 52. Edwards Lifesciences Mitral Regurgitation Product Offered
Table 53. Edwards Lifesciences Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Edwards Lifesciences Main Business
Table 55. Edwards Lifesciences Latest Developments
Table 56. Abbott Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 57. Abbott Mitral Regurgitation Product Offered
Table 58. Abbott Main Business
Table 59. Abbott Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Abbott Latest Developments
Table 61. CardioSolution Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 62. CardioSolution Mitral Regurgitation Product Offered
Table 63. CardioSolution Main Business
Table 64. CardioSolution Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. CardioSolution Latest Developments
Table 66. NeoChord Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 67. NeoChord Mitral Regurgitation Product Offered
Table 68. NeoChord Main Business
Table 69. NeoChord Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. NeoChord Latest Developments
Table 71. Mitralign Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 72. Mitralign Mitral Regurgitation Product Offered
Table 73. Mitralign Main Business
Table 74. Mitralign Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Mitralign Latest Developments
Table 76. Medtronic Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 77. Medtronic Mitral Regurgitation Product Offered
Table 78. Medtronic Main Business
Table 79. Medtronic Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Medtronic Latest Developments
Table 81. Boston Scientific Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 82. Boston Scientific Mitral Regurgitation Product Offered
Table 83. Boston Scientific Main Business
Table 84. Boston Scientific Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Boston Scientific Latest Developments
Table 86. Mitralix Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 87. Mitralix Mitral Regurgitation Product Offered
Table 88. Mitralix Main Business
Table 89. Mitralix Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Mitralix Latest Developments
Table 91. Shanghai Hanyu Medical Technology Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 92. Shanghai Hanyu Medical Technology Mitral Regurgitation Product Offered
Table 93. Shanghai Hanyu Medical Technology Main Business
Table 94. Shanghai Hanyu Medical Technology Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Shanghai Hanyu Medical Technology Latest Developments
Table 96. Valgen Holding Corporation Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 97. Valgen Holding Corporation Mitral Regurgitation Product Offered
Table 98. Valgen Holding Corporation Main Business
Table 99. Valgen Holding Corporation Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Valgen Holding Corporation Latest Developments
Table 101. NeoChord Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 102. NeoChord Mitral Regurgitation Product Offered
Table 103. NeoChord Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. NeoChord Main Business
Table 105. NeoChord Latest Developments
Table 106. CoreMedic Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 107. CoreMedic Mitral Regurgitation Product Offered
Table 108. CoreMedic Main Business
Table 109. CoreMedic Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. CoreMedic Latest Developments
Table 111. Babic Chord Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 112. Babic Chord Mitral Regurgitation Product Offered
Table 113. Babic Chord Main Business
Table 114. Babic Chord Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Babic Chord Latest Developments
Table 116. Gore Medical Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 117. Gore Medical Mitral Regurgitation Product Offered
Table 118. Gore Medical Main Business
Table 119. Gore Medical Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Gore Medical Latest Developments
Table 121. Valtech Cardio Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 122. Valtech Cardio Mitral Regurgitation Product Offered
Table 123. Valtech Cardio Main Business
Table 124. Valtech Cardio Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Valtech Cardio Latest Developments
Table 126. Transcardiac Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 127. Transcardiac Mitral Regurgitation Product Offered
Table 128. Transcardiac Main Business
Table 129. Transcardiac Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Transcardiac Latest Developments
Table 131. ChoRe Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 132. ChoRe Mitral Regurgitation Product Offered
Table 133. ChoRe Main Business
Table 134. ChoRe Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. ChoRe Latest Developments
Table 136. AVVIE Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 137. AVVIE Mitral Regurgitation Product Offered
Table 138. AVVIE Main Business
Table 139. AVVIE Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. AVVIE Latest Developments
Table 141. Cardiovalve Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 142. Cardiovalve Mitral Regurgitation Product Offered
Table 143. Cardiovalve Main Business
Table 144. Cardiovalve Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 145. Cardiovalve Latest Developments
Table 146. HighLife SAS Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 147. HighLife SAS Mitral Regurgitation Product Offered
Table 148. HighLife SAS Main Business
Table 149. HighLife SAS Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 150. HighLife SAS Latest Developments
Table 151. Neovasc Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 152. Neovasc Mitral Regurgitation Product Offered
Table 153. Neovasc Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 154. Neovasc Main Business
Table 155. Neovasc Latest Developments
Table 156. MitrAssist Lifesciences Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 157. MitrAssist Lifesciences Mitral Regurgitation Product Offered
Table 158. MitrAssist Lifesciences Main Business
Table 159. MitrAssist Lifesciences Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 160. MitrAssist Lifesciences Latest Developments
Table 161. Shanghai NewMed Medical Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 162. Shanghai NewMed Medical Mitral Regurgitation Product Offered
Table 163. Shanghai NewMed Medical Main Business
Table 164. Shanghai NewMed Medical Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 165. Shanghai NewMed Medical Latest Developments
Table 166. Peijia Medical Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 167. Peijia Medical Mitral Regurgitation Product Offered
Table 168. Peijia Medical Main Business
Table 169. Peijia Medical Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 170. Peijia Medical Latest Developments
Table 171. MicroPort CardioFlow Medtech Details, Company Type, Mitral Regurgitation Area Served and Its Competitors
Table 172. MicroPort CardioFlow Medtech Mitral Regurgitation Product Offered
Table 173. MicroPort CardioFlow Medtech Main Business
Table 174. MicroPort CardioFlow Medtech Mitral Regurgitation Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 175. MicroPort CardioFlow Medtech Latest Developments

LIST OF FIGURES

Figure 1. Mitral Regurgitation Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Mitral Regurgitation Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Mitral Regurgitation Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Mitral Regurgitation Sales Market Share by Country/Region (2022)
Figure 8. Mitral Regurgitation Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Mitral Regurgitation Market Size Market Share by Type in 2022
Figure 10. Mitral Regurgitation in Transapical
Figure 11. Global Mitral Regurgitation Market: Transapical (2018-2023) & ($ Millions)
Figure 12. Mitral Regurgitation in Via Stock and Via Interstitial
Figure 13. Global Mitral Regurgitation Market: Via Stock and Via Interstitial (2018-2023) & ($ Millions)
Figure 14. Mitral Regurgitation in Right Internal Jugular Vein
Figure 15. Global Mitral Regurgitation Market: Right Internal Jugular Vein (2018-2023) & ($ Millions)
Figure 16. Global Mitral Regurgitation Market Size Market Share by Application in 2022
Figure 17. Global Mitral Regurgitation Revenue Market Share by Player in 2022
Figure 18. Global Mitral Regurgitation Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Mitral Regurgitation Market Size 2018-2023 ($ Millions)
Figure 20. APAC Mitral Regurgitation Market Size 2018-2023 ($ Millions)
Figure 21. Europe Mitral Regurgitation Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Mitral Regurgitation Market Size 2018-2023 ($ Millions)
Figure 23. Americas Mitral Regurgitation Value Market Share by Country in 2022
Figure 24. United States Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Mitral Regurgitation Market Size Market Share by Region in 2022
Figure 29. APAC Mitral Regurgitation Market Size Market Share by Type in 2022
Figure 30. APAC Mitral Regurgitation Market Size Market Share by Application in 2022
Figure 31. China Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Mitral Regurgitation Market Size Market Share by Country in 2022
Figure 38. Europe Mitral Regurgitation Market Size Market Share by Type (2018-2023)
Figure 39. Europe Mitral Regurgitation Market Size Market Share by Application (2018-2023)
Figure 40. Germany Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Mitral Regurgitation Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Mitral Regurgitation Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Mitral Regurgitation Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Mitral Regurgitation Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 54. APAC Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 55. Europe Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 57. United States Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 58. Canada Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 61. China Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 62. Japan Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 63. Korea Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 65. India Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 66. Australia Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 67. Germany Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 68. France Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 69. UK Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 70. Italy Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 71. Russia Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 72. Spain Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 75. Israel Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Mitral Regurgitation Market Size 2024-2029 ($ Millions)
Figure 78. Global Mitral Regurgitation Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Mitral Regurgitation Market Size Market Share Forecast by Application (2024-2029)


More Publications